Accelerate Diagnostics, Inc. (0H8E.L)
USD 0.57
(-14.24%)
USD 0.57
(-14.24%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -61.61 Million USD | 1.4% |
| 2022 | -62.49 Million USD | 19.57% |
| 2021 | -77.7 Million USD | 0.65% |
| 2020 | -78.2 Million USD | 7.23% |
| 2019 | -84.3 Million USD | 4.55% |
| 2018 | -88.32 Million USD | -37.95% |
| 2017 | -64.02 Million USD | 3.53% |
| 2016 | -66.37 Million USD | -45.88% |
| 2015 | -45.49 Million USD | -47.09% |
| 2014 | -30.93 Million USD | -102.41% |
| 2013 | -15.28 Million USD | -87.28% |
| 2012 | -8.16 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -11.58 Million USD | 18.57% |
| 2024 Q1 | -14.23 Million USD | -9.48% |
| 2023 Q3 | 910 Thousand USD | 102.78% |
| 2023 Q1 | -16.79 Million USD | -14.96% |
| 2023 Q2 | -32.73 Million USD | -94.91% |
| 2023 Q4 | -12.99 Million USD | -1528.35% |
| 2023 FY | -61.61 Million USD | 1.4% |
| 2022 Q4 | -14.6 Million USD | 8.1% |
| 2022 Q3 | -15.89 Million USD | 14.18% |
| 2022 Q1 | -13.46 Million USD | 40.95% |
| 2022 FY | -62.49 Million USD | 19.57% |
| 2022 Q2 | -18.52 Million USD | -37.56% |
| 2021 Q3 | -8.98 Million USD | 58.54% |
| 2021 FY | -77.7 Million USD | 0.65% |
| 2021 Q1 | -24.23 Million USD | -28.17% |
| 2021 Q4 | -22.8 Million USD | -153.76% |
| 2021 Q2 | -21.67 Million USD | 10.58% |
| 2020 FY | -78.2 Million USD | 7.23% |
| 2020 Q1 | -21.3 Million USD | 0.12% |
| 2020 Q4 | -18.91 Million USD | -0.83% |
| 2020 Q3 | -18.75 Million USD | 2.46% |
| 2020 Q2 | -19.23 Million USD | 9.76% |
| 2019 Q2 | -20.81 Million USD | 4.17% |
| 2019 FY | -84.3 Million USD | 4.55% |
| 2019 Q4 | -21.33 Million USD | -4.41% |
| 2019 Q3 | -20.43 Million USD | 1.83% |
| 2019 Q1 | -21.72 Million USD | 2.12% |
| 2018 Q2 | -23.22 Million USD | -11.59% |
| 2018 Q1 | -20.81 Million USD | -27.72% |
| 2018 FY | -88.32 Million USD | -37.95% |
| 2018 Q4 | -22.19 Million USD | -0.42% |
| 2018 Q3 | -22.09 Million USD | 4.85% |
| 2017 Q1 | -14.2 Million USD | 11.99% |
| 2017 FY | -64.02 Million USD | 3.53% |
| 2017 Q4 | -16.29 Million USD | 4.57% |
| 2017 Q3 | -17.07 Million USD | -3.76% |
| 2017 Q2 | -16.45 Million USD | -15.89% |
| 2016 Q2 | -17.86 Million USD | -18.52% |
| 2016 Q3 | -17.29 Million USD | 3.17% |
| 2016 FY | -66.37 Million USD | -45.88% |
| 2016 Q4 | -16.13 Million USD | 6.73% |
| 2016 Q1 | -15.07 Million USD | -14.52% |
| 2015 Q2 | -12.25 Million USD | -37.71% |
| 2015 Q3 | -11.18 Million USD | 8.7% |
| 2015 FY | -45.49 Million USD | -47.09% |
| 2015 Q1 | -8.89 Million USD | -1.51% |
| 2015 Q4 | -13.16 Million USD | -17.67% |
| 2014 Q4 | -8.76 Million USD | 0.56% |
| 2014 Q3 | -8.81 Million USD | -8.12% |
| 2014 Q2 | -8.15 Million USD | -56.71% |
| 2014 Q1 | -5.2 Million USD | -0.81% |
| 2014 FY | -30.93 Million USD | -102.41% |
| 2013 Q4 | -5.16 Million USD | -35.9% |
| 2013 FY | -15.28 Million USD | -87.28% |
| 2013 Q2 | -3.77 Million USD | -48.18% |
| 2013 Q1 | -2.54 Million USD | 12.13% |
| 2013 Q3 | -3.79 Million USD | -0.53% |
| 2012 Q4 | -2.9 Million USD | 0.0% |
| 2012 FY | -8.16 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| QuidelOrtho Corporation | -10.1 Million USD | -510.079% |